Floatz logo

CHONDROITIN SULFATASE

Mucopolysaccharidosis IV Type A

BioMarin Pharmaceuticalprotein_peptideDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Mucopolysaccharidosis IV Type A cohort.

Asset / SponsorPhaseRating
Bmn 110
BioMarin Pharmaceutical
Phase 3BB
Losartan
Hospital de Clinicas de Porto Alegre
Phase 2CCC
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
University of California, San Francisco
Phase 1CC
Bmn 110
BioMarin Pharmaceutical
Phase 3NR

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →